Eisai to Use BioSeek's Drug Modeling Platform

The Japanese pharmaceutical developer has licensed the BioMap platform for drug toxicology research projects.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories